Purpose To make recommendations regarding the use of bisphosphonates and other bone-
modifying agents as adjuvant therapy for patients with breast cancer. Methods Cancer Care …

Eye involvement represents a common finding in patients with systemic autoimmune
diseases, particularly rheumatoid arthritis, Sjogren syndrome, seronegative …

In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

Abstract Every year the Breast Committee of the Arbeitsgemeinschaft Gynäkologische
Onkologie (German Gynecological Oncology Group, AGO), a group of gynecological …

Objective. Inflammatory ocular disease (IOD) is a rare but severe extraarticular manifestation
of rheumatoid arthritis (ExRA) with high mortality. The aim of our study was to examine …

OBJECTIVES Vision and hearing impairment may impact both life expectancy (LE) and
health expectancy, that is, duration of life with and without health problems, among older …

Objective To describe the clinical features of patients with bisphosphonate related ocular
side effects (BROSE). Methods The medical records of all patients with BROSE between …

Introduction: Zoledronate is commonly prescribed medication to maintain bone health
however, a rare side effect includes ocular inflammation. We report a case of simultaneous …

The bone morphogenetic protein (BMP) pathway is a promising new target for the design of
therapeutic agents for the treatment of low bone mass. This study optimized the structure of …

Bisphosphonates have evolved over the past decades from oral to more potent intravenous
preparations. Along with significant paradigm shift in the management of myeloma over the …